HomeCRXM • OTCMKTS
Gene Biotherapeutics Inc
$0.00
Feb 9, 9:10:00 PM GMT-4 · USD · OTCMKTS · Disclaimer
StockUS listed securityUS headquartered
Previous close
$0.00
Market cap
60.00 USD
Avg Volume
300.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD)2020Y/Y change
Revenue
Operating expense
1.26M50.80%
Net income
-517.90K-159.76%
Net profit margin
Earnings per share
EBITDA
-1.26M-61.83%
Effective tax rate
Total assets
Total liabilities
(USD)2020Y/Y change
Cash and short-term investments
386.03K96,406.75%
Total assets
566.98K1,500.06%
Total liabilities
5.14M5.12%
Total equity
-4.57M
Shares outstanding
64.93M
Price to book
-0.00
Return on assets
-261.90%
Return on capital
22.42%
Net change in cash
(USD)2020Y/Y change
Net income
-517.90K-159.76%
Cash from operations
-1.13M-726.03%
Cash from investing
-3.43K
Cash from financing
1.52M2,645.08%
Net change in cash
385.63K571.92%
Free cash flow
-707.67K51.75%
About
Founded
2003
Employees
3
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu